Maria Chiara Magnone

Maria-Chiara (Chiara) Magnone is Chief Scientific Officer at Abiologics, a Flagship Pioneering company leveraging generative AI and chemical synthesis to develop therapeutics beyond the limits of biology. At Abiologics she is leading the company’s scientific strategy, platform and pipeline, focused on the development of a new generation of protein therapeutics called Synteins™, mini-proteins made of D-amino acids. Chiara has extensive experience across various stages of drug development and a wide range of therapeutic areas. Prior to Abiologics she was at from Johnson & Johnson (J&J), where she was initially Vice President of Kidney Disease Research and Boston Site Head, and more recently Head of Discovery for the Cardiovascular, Metabolic, Retina and Pulmonary Hypertension therapeutic area. During her time at J&J, she led efforts to develop the kidney disease area strategy and pipeline through internal programs and external asset acquisition, and played a key role in advan